Abstract
The effects of omeprazole, a proton pump inhibitor, on gastric secretion and gastric or duodenal ulcers or erosions in rats were studied. Omeprazole, given intraduodenally, dose-dependently inhibited the gastric secretion (volume, acid and pepsin output) of pylorus-ligated rats. The antisecretory activity of omeprazole at 100 mg/kg persisted for 14 hr after treatment. Acutely induced gastric ulcers or erosions such as Shay ulcers, water-immersion stress-, indomethacin-, aspirin-, or prednisolone-induced erosions were all markedly inhibited by oral or intraduodenal administration of 10–100 mg/kg of omeprazole. The development of duodenal ulcers and gastric erosions caused by mepirizole was also potently inhibited by omeprazole at 3–10 mg/kg given orally. Repeated administration of omeprazole, 200 mg/kg/day in two divided doses for 14 days, significantly accelerated the spontaneous healing of acetic acid-induced gastric ulcers. The mechanism by which omeprazole inhibits the development of acute ulcers and accelerates healing of preexisting ulcers appears to be mainly due to its potent and longlasting antisecretory activity. The antisecretory and antiulcer activities of omeprazole are equal to or exceed those of cimetidine, both in the maximum inhibitory response and ED50 values.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sundell G, Sjöstrand SE, Olbe L: Gastric antisecretory effects of H 83/69, a benzimidazolyl-pyridylmethyl-sulphoxide. Acta Pharmacol Toxicol 41(Suppl):77, 1977
Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand SE, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H++K+)ATPase. Nature 290:159–161, 1981
Olbe L, Haglund U, Leth R, Lind T, Cederberg C, Ekenved G, Elander B, Fellenius E, Lundborg P, Wallmark B: Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology 83:193–198, 1982
Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T: Inhibition of acid secretion in isolated gastric glands by substituted benzimidazoles. Am J Physiol 243:505–510, 1982
Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 24:270–276, 1983
Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 22:79–89, 1938
Takagi K, Okabe S: The effects of drugs on the production and recovery processes of the stress ulcer. Jpn J Pharmacol 18:9–18, 1968
Takagi K, Kasuya Y, Watanabe K: Studies of the drugs for peptic ulcer, a reliable method for producing stress ulcer in rats. Chem Pharm Bull 12:465–472, 1964
Shay H, Komarov SA, Fels SS, Meranze D, Gruenstein M, Siplet H: A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 5:43–61, 1945
Kasuya Y, Urushidani T, Okabe S: Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn J Pharmacol 29:670–673, 1979
Okabe S, Takeuchi K, Nakamura K, Takagi K: Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rat. Jpn J Pharmacol 24:363–371, 1974
Robert A, Nezamis JE: Ulcerogenic property of steroids. Proc Soc Exp Biol Med 99:443–447, 1958
Okabe S, Ishihara Y, Inoo H, Tanaka H: Mepirizole-induced duodenal ulcers in rats and their pathogenesis. Dig Dis Sci 27:242–249, 1982
Takagi K, Okabe S, Saziki R: A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol 19:418–426, 1969
Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113, 1949
Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: The duration of the inhibitory effect of omeprazole on gastric acid secretion in healthy subjects. Scand J Gastroenterol 17(Suppl):14, 1982
Larsson H, Carlsson E, Junggren U, Olbe L, Sjostrand SE, Sundell G: Animal studies with omeprazole, a potent inhibitor of gastric acid secretion. Scand J Gastroenterol 17(Suppl):76, 1982
Mattsson H, Andersson K, Larsson H: Omeprazole provides protection against experimentally induced gastric mucosal lesions. Eur J Pharmacol 91:111–114, 1983
Kitagawa H, Fujiwara M, Osumi Y: Effects of waterimmersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 77:298–302, 1979
Watanabe K: Some pharmacological factors involved in formation and prevention of stress ulcer in rats. Chem Pharm Bull 14:101–107, 1966
Yano S, Akahane M, Harada M: Role of gastric motility in development of stress-induced gastric lesions of rats. Jpn J Pharmacol 28:607–615, 1978
Okabe S, Takeuchi K, Kunimi H, Kanno M, Kawashima M: Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats. Dig Dis Sci 28:1034–1042, 1983
Ishibashi A, Kasuya Y, Takeuchi K, Okabe S: Effects of 15 (S), 15-methyl-PGE2 methyl ester on healing of chronic gastric and duodenal ulcers in rats. Jpn J Pharmacol 29:807–810, 1979
Valcavi U, Caponi R, Brambilla A, Palmira M, Minoja F, Bernini F, Musanti R, Fumagalli R: Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals. Arzneim Forsch 32:657–663, 1982
Nagashima R, Hirano T: Selective binding of sucralfate to ulcer lesion. I. Experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate. Arzneim Forsch 30:80–83, 1980
Nagashima R, Hinohara Y, Hirano Y, Tohira Y, Kamiyama H: Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving14C-sucralfate or potassium14C-sucrose sulfate. Arzneim Forsch 30:84–88, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, O., Okada, Y. & Okabe, S. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Digest Dis Sci 29, 394–401 (1984). https://doi.org/10.1007/BF01296212
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296212